Strategy Asset Managers LLC Charles River Laboratories International, Inc. Transaction History

Strategy Asset Managers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$204.13 - $302.4 $5,307 - $7,862	-26 Reduced 1.4%	1,831 $392,000
Q1 2022 Apr 11, 2022	BUY	$255.51 - $362.11 $47,780 - $67,714	187 Added 11.2%	1,857 $527,000
Q4 2021 Jan 14, 2022	SELL	$351.38 - $448.68 $490,877 - $626,805	-1,397 Reduced 45.55%	1,670 $629,000
Q3 2021 Dec 14, 2021	BUY	$372.64 - $458.3 $811,982 - $998,635	2,179 Added 245.38%	3,067 $1.27 Million
Q2 2021 Aug 04, 2021	BUY	$294.17 - $371.65 $261,222 - $330,025	888 New	888 $328,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

Stay updated on Strategy Asset Managers LLC with notifications on news.